Have you ever seen a SINGLE ARM trial stopped for efficacy applying for regulatory approval?
I presume your question is rhetorical. Why on Earth would there be any impetus—ethical or otherwise—to stop a single-arm trial early for superior efficacy?
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”